IL33 and non-small cell lung carcinoma: Overexpression of IL-33, which has been suggested to correlate with tumor progression in humans, facilitates tumor growth and metastasis by upregulating GLUT1 and, consequently, enhancing glycolysis in NSCLC nude mice (Wang et al., 2016).